Biotechnology

CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset

* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...

2019-12-02 18:28 2510

Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)

SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...

2019-11-28 12:10 4381

Golden Meditech Announces FY2019/2020 Interim Results

Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...

2019-11-27 18:52 5063

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020

HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2019-11-27 05:16 11226

New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease

ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...

2019-11-27 02:31 1635

Japan and Singapore Grant CRISPR Patents to Merck

- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...

2019-11-26 21:00 2069

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 2385

USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November

TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...

2019-11-25 15:58 3587

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 5300

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2019-11-21 20:00 5881

Global Cord Blood Corp Comments on New Regulation

HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...

2019-11-20 20:00 5558

RhoVac Reports Interim Results on Immunological Response with RV001

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...

2019-11-18 17:13 1063

Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People

BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'sile...

2019-11-17 12:00 2270

World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers

* Phase 1A/1B safety and efficacy trials in Singapore completed within 8 months * TY014 also found to prevent vaccine related adverse effects in vaccinated volunteers SINGAPORE, Nov. 14, 2019 /PRNewswire/ -- Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF)...

2019-11-14 11:07 1314

Delivering Greater Throughput And Decreased Turnaround Time For Research Labs Is The Focus Of Leica Biosystems Next Generation Digital Pathology Scanner

VISTA, Calif., Nov. 14, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading ...

2019-11-14 08:00 1223

Merck Licenses CRISPR Gene-Editing Technology to Evotec

-- License to accelerate research, enable testing and development of new drugs DARMSTADT, Germany, Nov. 12, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has signed a license agreement providingEvotec SE access to Merck's foundational CRISPR intelle...

2019-11-12 21:00 2199

Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ -- Neurovalens , a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today launches its Modius SLEEP campaign on Indiegogo. The device follows the success of the Company's fir...

2019-11-12 20:18 2117

AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

SEATTLE, Nov. 12, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at theirSeattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of...

2019-11-12 20:00 2111

ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders

BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, andCyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery proce...

2019-11-11 21:45 1248

Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director

HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...

2019-11-11 19:30 4902